{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T20:41:43Z","timestamp":1793479303096,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"DOI":"10.1038\/s41591-026-04635-9","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T09:03:10Z","timestamp":1789117390000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Joint impact of pathological burden and cognitive resilience on Alzheimer\u2019s disease risk"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1152-6591","authenticated-orcid":false,"given":"Zhibo","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7018-6185","authenticated-orcid":false,"given":"Xinlei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7784-0643","authenticated-orcid":false,"given":"Simiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7569-5252","authenticated-orcid":false,"given":"Guoguang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4624-0336","authenticated-orcid":false,"given":"Jianping","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"4635_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.31887\/DCNS.2003.5.1\/hhippius","volume":"5","author":"H Hippius","year":"2003","unstructured":"Hippius, H. & Neund\u00f6rfer, G. The discovery of Alzheimer\u2019s disease. Dialogues Clin. Neurosci. 5, 101\u2013108 (2003).","journal-title":"Dialogues Clin. Neurosci."},{"key":"4635_CR2","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1126\/science.2961060","volume":"238","author":"JL Mark","year":"1987","unstructured":"Mark, J. L. Role of Alzheimer\u2019s protein is tangled. Science 238, 1352\u20131353 (1987).","journal-title":"Science"},{"key":"4635_CR3","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack Jr","year":"2024","unstructured":"Jack, C. R. Jr et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimers Dement. 20, 5143\u20135169 (2024).","journal-title":"Alzheimers Dement."},{"key":"4635_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck, C. H. et al. Lecanemab in early Alzheimer\u2019s disease. N. Engl. J. Med. 388, 9\u201321 (2023).","journal-title":"N. Engl. J. Med."},{"key":"4635_CR5","volume":"5","author":"Q-Q Tao","year":"2024","unstructured":"Tao, Q.-Q. et al. Alzheimer\u2019s disease early diagnostic and staging biomarkers revealed by large-scale cerebrospinal fluid and serum proteomic profiling. Innovation 5, 100544 (2024).","journal-title":"Innovation"},{"key":"4635_CR6","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1056\/NEJMoa2310168","volume":"390","author":"J Jia","year":"2024","unstructured":"Jia, J. et al. Biomarker changes during 20 years preceding Alzheimer\u2019s disease. N. Engl. J. Med. 390, 712\u2013722 (2024).","journal-title":"N. Engl. J. Med."},{"key":"4635_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105405","volume":"109","author":"A Feizpour","year":"2024","unstructured":"Feizpour, A. et al. Detection and staging of Alzheimer\u2019s disease by plasma pTau217 on a high throughput immunoassay platform. EBioMedicine 109, 105405 (2024).","journal-title":"EBioMedicine"},{"key":"4635_CR8","doi-asserted-by":"publisher","first-page":"100502","DOI":"10.1016\/j.tjpad.2026.100502","volume":"13","author":"K Kasuga","year":"2026","unstructured":"Kasuga, K. et al. Evaluation of plasma p-tau217 biomarkers in detecting amyloid pathology and predicting cognitive outcomes: observations from Japanese Alzheimer\u2019s disease neuroimaging initiative cohort. J. Prev. Alzheimers Dis. 13, 100502 (2026).","journal-title":"J. Prev. Alzheimers Dis."},{"key":"4635_CR9","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1212\/01.wnl.0000219668.47116.e6","volume":"66","author":"DA Bennett","year":"2006","unstructured":"Bennett, D. A. et al. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 66, 1837\u20131844 (2006).","journal-title":"Neurology"},{"key":"4635_CR10","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1038\/s41591-022-02049-x","volume":"28","author":"R Ossenkoppele","year":"2022","unstructured":"Ossenkoppele, R. et al. Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline. Nat. Med. 28, 2381\u20132387 (2022).","journal-title":"Nat. Med."},{"key":"4635_CR11","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1212\/WNL.0000000000005303","volume":"90","author":"EM Arenaza-Urquijo","year":"2018","unstructured":"Arenaza-Urquijo, E. M. & Vemuri, P. Resistance vs resilience to Alzheimer disease: clarifying terminology for preclinical studies. Neurology 90, 695\u2013703 (2018).","journal-title":"Neurology"},{"key":"4635_CR12","doi-asserted-by":"publisher","first-page":"fcae050","DOI":"10.1093\/braincomms\/fcae050","volume":"6","author":"D Negro","year":"2024","unstructured":"Negro, D. & Opazo, P. Cognitive resilience in Alzheimer\u2019s disease: from large-scale brain networks to synapses. Brain Commun. 6, fcae050 (2024).","journal-title":"Brain Commun."},{"key":"4635_CR13","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1001\/jamaneurol.2025.4974","volume":"83","author":"CA Brown","year":"2026","unstructured":"Brown, C. A. et al. Evaluation of copathology and clinical trajectories in individuals with tau-clinical mismatch. JAMA Neurol. 83, 126\u2013136 (2026).","journal-title":"JAMA Neurol."},{"key":"4635_CR14","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1038\/s41591-025-03565-2","volume":"31","author":"HS Oh","year":"2025","unstructured":"Oh, H. S. et al. A cerebrospinal fluid synaptic protein biomarker for prediction of cognitive resilience versus decline in Alzheimer\u2019s disease. Nat. Med. 31, 1592\u20131603 (2025).","journal-title":"Nat. Med."},{"key":"4635_CR15","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.neurobiolaging.2017.08.029","volume":"61","author":"WJ Jansen","year":"2018","unstructured":"Jansen, W. J. et al. Age and the association of dementia-related pathology with trajectories of cognitive decline. Neurobiol. Aging 61, 138\u2013145 (2018).","journal-title":"Neurobiol. Aging"},{"key":"4635_CR16","doi-asserted-by":"publisher","first-page":"e70713","DOI":"10.1002\/alz.70713","volume":"21","author":"E Palpatzis","year":"2025","unstructured":"Palpatzis, E. et al. Adaptive stress coping is associated with cognitive resilience in at-risk cognitively unimpaired older adults. Alzheimers Dement. 21, e70713 (2025).","journal-title":"Alzheimers Dement."},{"key":"4635_CR17","doi-asserted-by":"publisher","first-page":"e71051","DOI":"10.1002\/alz.71051","volume":"21","author":"J Stiver","year":"2025","unstructured":"Stiver, J. et al. Sleep duration promotes resistance and resilience to tau in older women at risk for Alzheimer\u2019s disease. Alzheimers Dement. 21, e71051 (2025).","journal-title":"Alzheimers Dement."},{"key":"4635_CR18","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1093\/brain\/awad100","volume":"146","author":"DI Bocancea","year":"2023","unstructured":"Bocancea, D. I. et al. Determinants of cognitive and brain resilience to tau pathology: a longitudinal analysis. Brain 146, 3719\u20133734 (2023).","journal-title":"Brain"},{"key":"4635_CR19","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1212\/WNL.0000000000012499","volume":"97","author":"DI Bocancea","year":"2021","unstructured":"Bocancea, D. I. et al. Measuring resilience and resistance in aging and Alzheimer disease using residual methods: a systematic review and meta-analysis. Neurology 97, 474\u2013488 (2021).","journal-title":"Neurology"},{"key":"4635_CR20","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s43587-022-00353-2","volume":"3","author":"L Dobyns","year":"2023","unstructured":"Dobyns, L. et al. An empirical measure of resilience explains individual differences in the effect of tau pathology on memory change in aging. Nat. Aging 3, 229\u2013237 (2023).","journal-title":"Nat. Aging"},{"key":"4635_CR21","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1001\/jamaneurol.2019.5154","volume":"77","author":"R Ossenkoppele","year":"2020","unstructured":"Ossenkoppele, R. et al. Assessment of Demographic, genetic, and imaging variables associated with brain resilience and cognitive resilience to pathological tau in patients with Alzheimer disease. JAMA Neurol. 77, 632\u2013642 (2020).","journal-title":"JAMA Neurol."},{"key":"4635_CR22","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3233\/JAD-190370","volume":"70","author":"D Wolf","year":"2019","unstructured":"Wolf, D., Fischer, F. U. & Fellgiebel, A. Impact of resilience on the association between amyloid-\u03b2 and longitudinal cognitive decline in cognitively healthy older adults. J. Alzheimers Dis. 70, 361\u2013370 (2019).","journal-title":"J. Alzheimers Dis."},{"key":"4635_CR23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40478-021-01154-1","volume":"9","author":"VK Ramanan","year":"2021","unstructured":"Ramanan, V. K. et al. Coping with brain amyloid: genetic heterogeneity and cognitive resilience to Alzheimer\u2019s pathophysiology. Acta Neuropathol. Commun. 9, 48 (2021).","journal-title":"Acta Neuropathol. Commun."},{"key":"4635_CR24","doi-asserted-by":"publisher","first-page":"k757","DOI":"10.1136\/bmj.k757","volume":"360","author":"MA Mansournia","year":"2018","unstructured":"Mansournia, M. A. & Altman, D. G. Population attributable fraction. BMJ 360, k757 (2018).","journal-title":"BMJ"},{"key":"4635_CR25","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","volume":"15","author":"FE Harrell Jr","year":"1996","unstructured":"Harrell, F. E. Jr, Lee, K. L. & Mark, D. B. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat. Med. 15, 361\u2013387 (1996).","journal-title":"Stat. Med."},{"key":"4635_CR26","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/EDE.0b013e3181c30fb2","volume":"21","author":"EW Steyerberg","year":"2010","unstructured":"Steyerberg, E. W. et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology 21, 128\u2013138 (2010).","journal-title":"Epidemiology"},{"key":"4635_CR27","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.jalz.2018.07.219","volume":"16","author":"Y Stern","year":"2020","unstructured":"Stern, Y. et al. Whitepaper: defining and investigating cognitive reserve, brain reserve, and brain maintenance. Alzheimers Dement. 16, 1305\u20131311 (2020).","journal-title":"Alzheimers Dement."},{"key":"4635_CR28","doi-asserted-by":"publisher","first-page":"c2289","DOI":"10.1136\/bmj.c2289","volume":"340","author":"JA Hutcheon","year":"2010","unstructured":"Hutcheon, J. A., Chiolero, A. & Hanley, J. A. Random measurement error and regression dilution bias. BMJ 340, c2289 (2010).","journal-title":"BMJ"},{"key":"4635_CR29","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1093\/ije\/dyi060","volume":"34","author":"AM Jurek","year":"2005","unstructured":"Jurek, A. M., Greenland, S., Maldonado, G. & Church, T. R. Proper interpretation of non-differential misclassification effects: expectations vs observations. Int. J. Epidemiol. 34, 680\u2013687 (2005).","journal-title":"Int. J. Epidemiol."},{"key":"4635_CR30","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1212\/WNL.0b013e3181cb3e25","volume":"74","author":"RC Petersen","year":"2010","unstructured":"Petersen, R. C. et al. Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI): clinical characterization. Neurology 74, 201\u2013209 (2010).","journal-title":"Neurology"},{"key":"4635_CR31","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jalz.2016.07.150","volume":"13","author":"MW Weiner","year":"2017","unstructured":"Weiner, M. W. et al. Recent publications from the Alzheimer\u2019s Disease Neuroimaging Initiative: reviewing progress toward improved AD clinical trials. Alzheimers Dement. 13, e1\u2013e85 (2017).","journal-title":"Alzheimers Dement."},{"key":"4635_CR32","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nrneurol.2017.162","volume":"14","author":"JC Polanco","year":"2018","unstructured":"Polanco, J. C. et al. Amyloid-\u03b2 and tau complexity\u2014towards improved biomarkers and targeted therapies. Nat. Rev. Neurol. 14, 22\u201339 (2018).","journal-title":"Nat. Rev. Neurol."},{"key":"4635_CR33","doi-asserted-by":"publisher","first-page":"3777","DOI":"10.1016\/j.scib.2024.09.042","volume":"69","author":"J Shi","year":"2024","unstructured":"Shi, J. et al. Now and future: strategies for diagnosis, prevention and therapies for Alzheimer\u2019s disease. Sci. Bull. 69, 3777\u20133784 (2024).","journal-title":"Sci. Bull."},{"key":"4635_CR34","doi-asserted-by":"publisher","first-page":"102711","DOI":"10.1016\/j.arr.2025.102711","volume":"106","author":"B Jia","year":"2025","unstructured":"Jia, B., Xu, Y. & Zhu, X. Cognitive resilience in Alzheimer\u2019s disease: mechanism and potential clinical intervention. Ageing Res. Rev. 106, 102711 (2025).","journal-title":"Ageing Res. Rev."},{"key":"4635_CR35","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41582-022-00642-9","volume":"18","author":"T Gomez-Isla","year":"2022","unstructured":"Gomez-Isla, T. & Frosch, M. P. Lesions without symptoms: understanding resilience to Alzheimer disease neuropathological changes. Nat. Rev. Neurol. 18, 323\u2013332 (2022).","journal-title":"Nat. Rev. Neurol."},{"key":"4635_CR36","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41582-025-01094-7","volume":"21","author":"RN Taddei","year":"2025","unstructured":"Taddei, R. N. & Duff, K. E. Synapse vulnerability and resilience across the clinical spectrum of dementias. Nat. Rev. Neurol. 21, 353\u2013369 (2025).","journal-title":"Nat. Rev. Neurol."},{"key":"4635_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42596-6","volume":"14","author":"H Cai","year":"2023","unstructured":"Cai, H., Pang, Y., Fu, X., Ren, Z. & Jia, L. Plasma biomarkers predict Alzheimer\u2019s disease before clinical onset in Chinese cohorts. Nat. Commun. 14, 6747 (2023).","journal-title":"Nat. Commun."},{"key":"4635_CR38","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1001\/jamaneurol.2014.803","volume":"71","author":"MC Donohue","year":"2014","unstructured":"Donohue, M. C. et al. The preclinical Alzheimer cognitive composite: measuring amyloid-related decline. JAMA Neurol. 71, 961\u2013970 (2014).","journal-title":"JAMA Neurol."},{"key":"4635_CR39","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1136\/jnnp-2015-312383","volume":"87","author":"J Wang","year":"2016","unstructured":"Wang, J. et al. ADCOMS: a composite clinical outcome for prodromal Alzheimer\u2019s disease trials. J. Neurol. Neurosurg. Psychiatry 87, 993\u2013999 (2016).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"4635_CR40","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1007\/s11682-012-9186-z","volume":"6","author":"PK Crane","year":"2012","unstructured":"Crane, P. K. et al. Development and assessment of a composite score for memory in the Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI). Brain Imaging Behav. 6, 502\u2013516 (2012).","journal-title":"Brain Imaging Behav."},{"key":"4635_CR41","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","volume":"256","author":"RC Petersen","year":"2004","unstructured":"Petersen, R. C. Mild cognitive impairment as a diagnostic entity. J. Intern. Med. 256, 183\u2013194 (2004).","journal-title":"J. Intern. Med."},{"key":"4635_CR42","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann, G. M. et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 7, 263\u2013269 (2011).","journal-title":"Alzheimers Dement."},{"key":"4635_CR43","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","volume":"7","author":"MS Albert","year":"2011","unstructured":"Albert, M. S. et al. The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 7, 270\u2013279 (2011).","journal-title":"Alzheimers Dement."},{"key":"4635_CR44","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1002\/alz.12997","volume":"19","author":"Z-B Wang","year":"2023","unstructured":"Wang, Z.-B. et al. Differences between ante mortem Alzheimer\u2019s disease biomarkers in predicting neuropathology at autopsy. Alzheimer Dement. 19, 3613\u20133624 (2023).","journal-title":"Alzheimer Dement."},{"key":"4635_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70185","volume":"21","author":"S Mutel","year":"2025","unstructured":"Mutel, S. et al. Resilience in Alzheimer\u2019s disease: impact of operationalization and methodological choices. Alzheimers Dement. 21, e70185 (2025).","journal-title":"Alzheimers Dement."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-026-04635-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-026-04635-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-026-04635-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T09:31:01Z","timestamp":1789723861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-026-04635-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":45,"alternative-id":["4635"],"URL":"https:\/\/doi.org\/10.1038\/s41591-026-04635-9","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"assertion":[{"value":"17 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.J. reports grants from the Key Project of the National Natural Science Foundation of China (U20A20354) and the Beijing Brain Initiative from the Beijing Municipal Science and Technology Commission (Z201100005520016, Z201100005520017); consulting fees from Eisai, Shineway Zhejiang Hisun, CSPC-NBP, Eli Lilly, AstraZeneca, Novo Nordisk and Novartis; honoraria for a presentation at the Third China\u2013Denmark Clinical Research and Health Development International Cooperation Conference; honoraria for an Eisai AD webinar; honoraria as Chair of the Annual Meeting of the Neurology Committee of Chinese Medical Association; and honoraria as the Chair of the Annual Meeting of the Neurologist Society of the Chinese Medical Doctor Association, all unrelated to the present work. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}